v3.19.3

Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Sep. 30, 2019	Dec. 31, 2018
Current assets:
Cash and cash equivalents	$ 71,961	$ 61,645
Short-term marketable securities	203,474	148,149
Accounts receivable	55,875	51,531
Prepaid expenses and other current assets	13,726	13,511
Total current assets	345,036	274,836
Property and equipment, net	46,491	39,532
Operating lease right-of-use assets	50,082
Long-term marketable securities		4,066
Other assets	18,802	15,938
Total assets	460,411	334,372
Current liabilities:
Accounts payable	6,431	8,849
Accrued compensation and employee benefits	31,934	34,457
Accrued expenses and other current liabilities	14,743	15,870
Current portion of operating lease liabilities	4,530
Other current liabilities	262	600
Total current liabilities	57,900	59,776
Operating lease liabilities	50,786
Other liabilities	2,352	4,436
Commitments and contingencies
Stockholders' equity:
Common stock	3	3
Additional paid-in capital	538,083	506,679
Accumulated other comprehensive income (loss)	42	(87)
Accumulated deficit	(188,755)	(206,325)
Treasury stock, at cost		(30,110)
Total stockholders' equity	349,373	270,160
Total liabilities and stockholders' equity	$ 460,411	$ 334,372

Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).

GENOMIC HEALTH INC 10-Q